Application deadline: 12:00pm ET (GMT -5) on April 30, 2015.

Eligible researchers should complete the Gut Microbiome Grant Application and submit this to DNA Genotek by 12:00pm ET (GMT -5) on April 30, 2015.

Awards & Amounts

2 Awards of:

• (up to) 100 OMNIgene•GUT microbiome collection kits to facilitate collection and stabilization of fecal/stool samples for use in the execution of the proposal.
• (up to) $15,000 USD in services* OR (up to) $10,000 USD for researchers who have their own labs.

1 Award of:

• (up to) 100 OMNIgene•GUT microbiome collection kits to facilitate collection and stabilization of fecal/stool samples for use in the execution of the proposal.
• (up to) $5,000 USD.

* Services may include a selection from: Study Optimization Consulting, Extraction, Sequencing, and/or Analysis & Reporting

Winner Announced

Update: the winners will be announced on www.dnagenotek.com/gutgrant on June 4, 2015.

Program rules

1. One entry per investigative team. Investigators in all countries are eligible.
2. All submitted materials must be in English.
3. The research described in the submission must be in the microbiome field and must use feces as the sample type.
4. Applicants who have a relative or member of their household currently employed by DNA Genotek are ineligible to enter.
5. Applicant is responsible for ensuring that all necessary and legally required informed consents, authorizations, approvals, and permission have been obtained in order to participate in this program including any required Internal Review Board (IRB) approvals.
6. Applicant agrees that the project will be complete within 1 year of the date of the award being received, if selected as a winner.
7. Institutional overhead costs are restricted to a maximum of 5% of the funds awarded as part of this program.
8. Applicants must agree to DNA Genotek’s product terms and conditions and services terms and conditions applicable to the OMNIgene•GUT fecal/stool collection kits.
9. Applicants must allow DNA Genotek to publicly announce their name, project name or area of research, and institution or company if they are selected as a winner.
10. DNA Genotek will keep all abstracts, applicant names and institutions, and all information submitted in the program applications process confidential, except in the case of the winners.
11. All decisions of the selection committee are final. The selection process is confidential.
12. The winner agrees to provide a written progress report on the project to DNA Genotek 6 months after the receipt of the award.
13. The winner agrees that within 30 days of the completion date of the project, they will submit a written financial report outlining the use of award funds as well as a written report on all findings, data, results, and information as a result of the project.
14. Applications will only be accepted for consideration if sent to DNA Genotek via the online application form. All other applications will be rejected and destroyed. Under no circumstances will any materials be returned.
15. Applicants agree to comply with the Additional Gut Microbiome Grant Programs terms and conditions. (See below)

Additional Grant Program Terms & Conditions

1. The applicant agrees that they have read, understood and agree to be bound by all of the DNA Genotek Gut Microbiome Grant Program Rules and by these Additional Terms and Conditions.
2. By applying, the applicant represents and warrants that:
   1. They have obtained all required authorizations and permissions from their institution or company,
   2. They will not violate any of their institution's or company's rules, policies, or procedures by applying to this Gut Microbiome Grant Program,
   3. Their institution or company has agreed to be bound by all of the Gut Microbiome Grant Program Rules (See above) and by these Additional Terms and Conditions.
3. DNA Genotek is not responsible for applicant's actions or decisions or those of their employees or agents.
4. DNA Genotek reserves the right to discontinue or modify the Gut Microbiome Grant Program at any time and for any reason. In such event, DNA Genotek will post a notice on this website (www.dnagenotek.com/gutgrant). In the event of discontinuation of the Gut Microbiome Grant Program, DNA Genotek will have no liability to any existing or possible applicant or applicant's employees or agents for such cancellation or modification.
5. DNA Genotek may refuse to award the prize to any or all applicants if DNA Genotek determines at its sole discretion that the granting of such award would likely result in a violation of an applicable federal, state or local law, rule or policy.
6. DNA Genotek will withhold the award until the winner has obtained all necessary IRB approvals.
7. The successful applicant will own any intellectual property arising from the results that are free of any encumbrances stipulated in Section 10 of the Product Terms and Conditions, and may take such steps as it may decide from time to time, and at its own expense, to register and maintain any protection for that intellectual property, including filing and prosecuting patent applications for any of the results.
8. The winner and their employees and agents hereby irrevocably authorize DNA Genotek to copy, exhibit, publish, and distribute images, audio, video and other works based upon the submission, oral discussions, and presentations, solely for DNA Genotek's marketing purposes. Applicant hereby releases and holds harmless DNA Genotek and forever discharges DNA Genotek from any and all claims, demands, and causes of action which may arise by reason of this authorization.
9. Each applicant is responsible for all of their own costs, and the costs of its employees and agents, that are incurred or that may be incurred in connection with this Gut Microbiome Grant Program, including, without limitation, any tax liability and any costs associated with entering into and participating in this Gut Microbiome Grant Program, developing ideas and materials, submitting materials, traveling and generally participating in the Gut Microbiome Grant Program.
10. Applicant understands and agrees that no ideas, information, or materials that are submitted to or otherwise provided to DNA Genotek in connection with this Gut Microbiome Grant Program will be returned.
11. Each applicant and their employees and agents agree to accept and abide by the Gut Microbiome Grant Program Rules and agrees that any dispute with regard to the conduct of the Gut Microbiome Grant Program, rule interpretation or the award of the prizes, shall be resolved by DNA Genotek, whose decision shall be binding and final. By participating, each applicant and their employees and agents agree to release and hold harmless DNA Genotek and all of its officers, directors, employees, agents and representatives, from any injury, loss or damage, including death or property damage, due in-whole or in-part, directly or indirectly to the acceptance, use, or misuse of a grant, participation in any Gut Microbiome Grant Program-related activity, or participation in the Gut Microbiome Grant Program. DNA Genotek is not responsible for any typographical or other error herein, administration of the Gut Microbiome Grant Program or in the announcement of the award, including such error as may give an erroneous indication that an award has been won.
12. The funds awarded under this Gut Microbiome Grant Program may not be used for any purposes other than those described in the application form. Any products awarded under this Gut Microbiome Grant Program may not be re-sold, or used for any other purposes other than that described in the Gut Microbiome Grant Program application. Unused products must be returned upon completion of the project.
13. IN NO EVENT SHALL DNA GENOTEK, ITS OFFICERS, DIRECTORS, EMPLOYEES, OR AGENTS, BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES WHATSOEVER ARISING UNDER OR AS A RESULT OF ENTRANCE IN OR PARTICIPATION IN THE GRANT PROGRAM, WHETHER BASED ON WARRANTY, CONTRACT, TORT, STRICT LIABILITY, OR ANY OTHER LEGAL THEORY, AND WHETHER OR NOT DNA GENOTEK IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, THE FOREGOING LIMITATION OF LIABILITY SHALL APPLY TO THE FULLEST EXTENT PERMITTED BY LAW. THE TOTAL LIABILITY OF DNA GENOTEK ARISING UNDER OR RELATING TO THIS GRANT PROGRAM SHALL NOT EXCEED THE TOTAL VALUE OF THE PRIZE AWARDED TO THE SUCCESSFUL APPLICANT UNDER THIS GRANT PROGRAM.
14. For the purpose of this Agreement, the term "Affiliate" shall mean any corporation or other business entity controlling, controlled by or under common control with a party; and for such purpose, "control" shall mean direct or indirect ownership of: i) fifty percent (50%) or more of the voting interest in such corporation or other entity; ii) fifty percent (50%) or more of the interest in the profit or income in the case of an entity other than a corporation; or iii) in the case of a partnership, control of the general partner. The name of each party appearing herein or in any Grant Program application shall be deemed to be the name of each such Affiliate of that party to the extent necessary to carry out the intent of this Agreement, and provided further that the performance of the obligations of any such Affiliate shall be deemed guaranteed by the party to this Agreement.